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Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear
whether this association is causal, or due to shared factors that influence both behaviours
such as a shared genetic liability. The aim of this study was to investigate whether polygenic
risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes.
Methods and findings
Smoking initiation PRS were calculated for young adults (N = 7,859, mean age = 24 years,
51% male) of European ancestry in the Avon Longitudinal Study of Parents and Children, a
prospective birth cohort study initiated in 1991. PRS were calculated using the GWAS &
Sequencing Consortium of Alcohol and Nicotine use (GSCAN) summary statistics. Five
thresholds ranging from 5 × 10−8 to 0.5 were used to calculate 5 PRS for each individual.
Using logistic regression, we investigated the association between smoking initiation PRS
and the main outcome, self-reported e-cigarette use (n = 2,894, measured between 2016
and 2017), as well as self-reported smoking initiation and 8 negative control outcomes
(socioeconomic position at birth, externalising disorders in childhood, and risk-taking in
young adulthood). A total of 878 young adults (30%) had ever used e-cigarettes at 24 years,
and 150 (5%) were regular e-cigarette users at 24 years. We observed positive associations
of similar magnitude between smoking initiation PRS (created using the p < 5 × 10−8 thresh-
old) and both smoking initiation (odds ratio (OR) = 1.29, 95% CI 1.19 to 1.39, p < 0.001) and
ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34, p < 0.001) by the age of 24 years, indi-
cating that a genetic predisposition to smoking initiation is associated with an increased risk
of using e-cigarettes. At lower p-value thresholds, we observed an association between
smoking initiation PRS and ever e-cigarette use among never smokers. We also found evi-
dence of associations between smoking initiation PRS and some negative control out-
comes, particularly when less stringent p-value thresholds were used to create the PRS, but
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Conclusions
Our results indicate that there may be a shared genetic aetiology between smoking and e-
cigarette use, and also with socioeconomic position, externalising disorders in childhood,
and risky behaviour more generally. This indicates that there may be a common genetic vul-
nerability to both smoking and e-cigarette use, which may reflect a broad risk-taking
phenotype.
Author summary
Why was this study done?
• Some individuals are more likely to smoke due to their genetics, but little is currently
known about the genetic influences on e-cigarette use.
• Given that many people who use e-cigarettes have smoked before, it is likely that there
may be an overlap between genetic influences on smoking and e-cigarette use.
• Such an overlap may explain why people who use e-cigarettes but have not smoked
before are more likely to go on to start smoking later.
What did the researchers do and find?
• We examined the association between genetic variants associated with smoking initia-
tion and both e-cigarette use and risk-taking behaviour in a cohort of 2,894 young
adults.
• Our results indicate that the genetic factors that influence smoking initiation are simi-
larly related to e-cigarette use and risk-taking behaviours.
What do these findings mean?
• Smoking may cause people to use e-cigarettes (i.e., to stop smoking), but there may also
be an underlying genetic predisposition to risk-taking which influences the likelihood
that someone will both smoke and use e-cigarettes.
• The findings could have important implications for policy—if young people are predis-
posed to both smoking and using e-cigarettes, bans which aim to prevent e-cigarette use
may encourage smoking where only cigarettes are available.
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Introduction
There are an estimated 3.6 million electronic cigarette (e-cigarette) users in Great Britain [1],
and evidence is growing that e-cigarettes are effective in helping tobacco smokers quit [2,3].
The use of e-cigarettes for smoking cessation is common among young adults in the United
Kingdom [4]; therefore, it would be logical to assume that smoking causally influences e-ciga-
rette use in this population. However, some studies have shown an association between e-ciga-
rette use and subsequent smoking among nonsmokers, which suggests the possibility that e-
cigarette use may also act as a gateway to smoking (sometimes referred to as the gateway
hypothesis), particularly among adolescents. A recent meta-analysis found that for young peo-
ple aged 30 years or younger, there is a strong and consistent positive association between e-
cigarette use among never smokers and later smoking, but that there is currently insufficient
evidence to conclude that this association is causal [5]. Understanding more about the nature
of the association between smoking and e-cigarette use, particularly in young adulthood, is
vital to inform tobacco control policies that aim to prevent youth smoking initiation by
restricting access to e-cigarettes. Specifically, it is important to understand whether the associa-
tion found among young adults is causal, or due to other factors that influence both smoking
and e-cigarette use independently.
For example, there is some evidence for a shared genetic liability to both smoking and e-cig-
arette use [6]. This could indicate a causal relationship in that genetic variants influence smok-
ing which then increases the probability of e-cigarette use (i.e., vertical pleiotropy), or it could
be due to genetic variants that influence a phenotype which consequently influences both
behaviours (i.e., horizontal pleiotropy) [7]. One biologically plausible explanation for a genetic
link between smoking and e-cigarette use is that they are both influenced by the same genetic
variants that influence an individual’s response to nicotine or their nicotine metabolism. How-
ever, evidence suggests that some of the genetic influence on smoking initiation is mediated by
personality traits, such as risk-taking and impulsivity, that influence (among other things)
smoking uptake [8]. Allegrini and colleagues [6] suggest that a genetic link between smoking
and e-cigarette use may reflect these personality traits (i.e., a genetic liability to take risks may
influence an individual’s likelihood of initiating smoking and e-cigarette use).
Using genetic variants, we can explore whether smoking is associated with e-cigarette use,
and which factors or mechanisms may influence the association. Ideally, we would explore the
genetic overlap between smoking and e-cigarette use by comparing the genetic variants identi-
fied in genome-wide association studies (GWAS) of each behaviour, but at present, there are
no large, well-powered GWAS of e-cigarette use. However, a GWAS of various smoking
behaviours has recently been published [9], which identified 378 single nucleotide polymor-
phisms (SNPs) associated with smoking initiation. Using these SNPs, smoking initiation poly-
genic risk scores (PRS) can be created and associations between these PRS and a range of
outcomes examined.
Causality cannot be inferred from such analyses, but negative control outcomes can be used
to inform the overall evaluation of whether an association is causal via a hypothesised route.
Negative controls are outcomes which are not plausibly caused by the exposure—for example,
smoking is associated with risk of dying by suicide (which is biologically plausible), but equally
strongly associated with risk of dying by homicide (which is not), casting doubt on the causal
nature of the former association [10]. Triangulating evidence from outcomes where a simple
biological pathway from smoking to the outcome is implausible (e.g., gambling), or impossible
(e.g., externalising behaviour or socioeconomic position [SEP] in childhood, before smoking
has occurred) can aid consideration of potential pathways by which smoking and e-cigarette
use may share a genetic predisposition. These potential pathways (displayed in Fig 1) include a
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biological pathway from smoking to e-cigarette use (i.e., vertical pleiotropy), a shared genetic
predisposition which influences smoking and e-cigarette use independently (i.e., horizontal
pleiotropy), or a genetic liability to a broader, risk-taking phenotype (i.e., a shared risk factor)
which causes both smoking and e-cigarette use. Alternatively, triangulation could help us con-
sider whether an association is due to a shared genetic predisposition between parents and off-
spring. Where parents share their offspring’s smoking initiation predisposition, they are likely
to expose their offspring to cigarette smoke in utero or in childhood. Consequently, an appar-
ent effect of a child’s own genetic variants may be a result of their prenatal or postnatal envi-
ronment due to a dynastic effect of their parents’ genetic variants. If associations are only
found between smoking initiation PRS and e-cigarette use, but not negative control outcomes,
this would strengthen the vertical pleiotropy interpretation; however, if an association is also
found with negative control outcomes, this would indicate that horizontal pleiotropy is occur-
ring or that shared parent–offspring genetic predisposition may be confounding the
association.
Additionally, using varying p-value thresholds to create PRS could help to identify the pres-
ence of horizontal pleiotropy. Calculating PRS at less strict p-value thresholds than the stan-
dard genome-wide significant threshold increases the percentage variance in the phenotype
explained by the score, and thus increases power to detect an association. However, using less
stringent thresholds will also tend to increase the likelihood of including genetic variants
which are related to other factors, making the PRS less specific to the exposure of interest (and
may eventually result in PRS which explain less variance in the exposure). The more SNPs
Fig 1. Potential models of shared liability for the relationship between genetic predisposition to smoking initiation and e-cigarette
use.
https://doi.org/10.1371/journal.pmed.1003555.g001
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included in a PRS, the less likely it is that the effect of each variant on the trait of interest is pro-
portional to the effect of the trait of interest on the exposure, and the more likely it is propor-
tional to the effects on other (horizontally pleiotropic) traits [11], increasing the likelihood that
any associations found between the PRS and an outcome could be due to horizontal pleiot-
ropy. Triangulating evidence from a variety of thresholds and a variety of outcomes may pro-
vide a clearer picture of the true association. Associations observed when more stringent PRS
thresholds are used could be due to a causal effect of smoking, and consistent magnitudes of
association at less stringent thresholds could indicate that any associations observed are driven
by the effect of the more specific PRS. However, increasing magnitudes of association observed
at less stringent thresholds (particularly among negative control outcomes) may indicate hori-
zontal pleiotropy is driving part of the associations observed.
We aimed to investigate whether smoking initiation PRS are associated with ever use of e-
cigarettes in young adulthood. Given the possibility of a shared liability mechanism (e.g., an
underlying risk-taking phenotype), we also aimed to explore any associations with outcomes
that are not plausibly biologically related (e.g., gambling) or that precede smoking (e.g., hyper-
activity in childhood), to determine whether the association between smoking and e-cigarette
use could reflect a broader risk-taking phenotype captured by the smoking initiation PRS (i.e.,
a common risk factor). Finally, we aimed to explore whether the smoking initiation PRS may
be capturing broader social influences on smoking (e.g., socioeconomic position at birth)
which cannot plausibly have been a causal effect of the young adult’s own smoking.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guideline (S1 STROBE Checklist).
Data sources
Two data sources were utilised for this study: the GWAS & Sequencing Consortium of Alcohol
and Nicotine use (the discovery sample; GSCAN) and the Avon Longitudinal Study of Parents
and Children (the target sample; ALSPAC) [9,12,13].
GSCAN. GSCAN report summary level statistics from a GWAS of smoking initiation [9].
This GWAS was based on 1,232,091 participants from 29 cohorts. In order to eliminate data
overlap with the target sample, summary statistics were obtained (through correspondence
with GSCAN) with ALSPAC participants removed (N = 11,345). 23andMe participants
(N = 599,289) were also excluded from this summary data due to data sharing restrictions. The
remaining summary data consisted of data from 621,457 participants. Smoking initiation was
defined as ever being a regular smoker. The exact definition varied across the cohorts included
in the consortium, with 3 different definitions: (1) Have you smoked over 100 cigarettes over
the course of your life? (2) Have you ever smoked every day for at least a month? (3) Have you
ever smoked regularly? The majority of the SNPs identified were intergenic with no known
function, but glutamate and dopaminergic gene pathways were enriched for smoking initia-
tion. Also, the rs6265 variant (a nonsynonymous SNP in the BDNF gene) which has previously
been found to be associated with smoking initiation [14] was also associated with smoking ini-
tiation in GSCAN. A comprehensive description of the genetic variants, and the genes they are
within (e.g., PPP1R1B, GRIN2A, HOMER2), have been described previously [9].
ALSPAC. The target sample consisted of participants from ALSPAC [12,13], a prospective
cohort study with extensive data from birth to young adulthood (including genetic data). This
study recruited pregnant women residing in Avon, UK with expected delivery dates between 1
April 1991 and 31 December 1992. The phases of enrolment are described in detail in the cohort
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profile paper and its update [15]. A total of 15,454 mothers were recruited, resulting in 15,589
foetuses. Of these, 14,901 children were alive at 1 year of age. The study website contains details
of all the data that are available via a fully searchable data dictionary and variable search tool
(http://www.bristol.ac.uk/alspac/researchers/our-data/). After samples that did not pass quality
control were removed, genetic data were available for 9,085 young adults. PRS were created for
7,859 unrelated individuals of European ancestry. Of these individuals, 2,905 also had data for
our main outcome (e-cigarette use) at 24 years (the most recent time point at which detailed e-
cigarette use data were collected prior to analysis). ALSPAC study data from 22 years onwards
were collected and managed using REDCap electronic data capture tools hosted at the Univer-
sity of Bristol [16]. Sample sizes varied by outcome due to restrictions (e.g., restricting to never
smokers) and differing time points of measurement (i.e., missing data).
Ethics
Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and
the Local Research Ethics Committees. Consent for biological samples has been collected in
accordance with the Human Tissue Act (2004). Written informed consent for the use of data
collected via questionnaires and clinics was obtained from participants following the recommen-
dations of the ALSPAC Ethics and Law Committee at the time of study initiation (i.e., 1991).
Polygenic risk scores
Summary data from GSCAN (excluding ALSPAC and 23andMe, N = 621,457) were used to
select SNPs associated with smoking initiation. Betas were converted to log odds ratios (ORs).
Each participant was given a score which indicated the average number of risk alleles (0, 1, or 2
effect alleles) they possessed for the selected SNPs. Scores were weighted (i.e., multiplied) by the
regression coefficients from the summary statistics (with ALSPAC and 23andMe removed),
then standardised by transforming to z-scores. Five p-value thresholds (5 × 10−8, 0.0005, 0.005,
0.05, 0.5) were used to determine 5 groups of SNPs to be included in 5 different PRS for each
participant. PLINK was used to determine PRS at the p< 5 × 10−8 threshold using the SNPs
which met the genome-wide significance threshold in the GSCAN GWAS of smoking initiation
[9]. PRSice software was used to calculate the PRS at all other thresholds [17]. The data acquired
from GSCAN was pruned for SNPs with a Minor Allele Frequency (MAF)> 0.001 where at
least 10% of the maximum sample size had SNP data available in at least 3 of the consortium
studies. SNPs were clumped to ensure low linkage disequilibrium (r2 < 0.1).
Outcomes
Detailed information regarding the phenotype data including the questions and answer
options provided in the questionnaires are available in S1 Table.
E-cigarette use. At 24 years (between 2016 and 2017), outcome data were collected via
questionnaire on whether participants had ever used e-cigarettes. Ever use was defined as ever
having used/vaped an e-cigarette or other vaping device.
Smoking. Self-reported smoking initiation and ever smoking were included as positive
control outcomes (i.e., outcomes for which an association with the exposure is expected).
Smoking initiation by 24 years was defined as having smoked 100 or more cigarettes in their
lifetime. Ever smoking by 24 years was defined as having ever smoked a whole cigarette
(including roll-ups).
Negative controls. Four negative control outcomes at age 23 and 24 were included in the
analysis: high number of sexual partners, having been in trouble with the law, ever gambling,
and enjoying taking risks. These were selected on the basis of being related to broad risk-taking
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behaviour, but where a causal pathway from smoking was not considered biologically plausi-
ble. Three negative control outcomes at age 7 were included: hyperactivity, conduct disorder
(CD), and oppositional defiant disorder (ODD). These externalising disorders are indicators
of impulsivity and were selected on the basis that few (if any) children at this age have smoked,
ruling out a causal pathway from their own smoking to these outcomes. Parental SEP, which
was measured at birth, was also included in the analysis. This outcome was based on highest
occupation of both parents at birth (preceding smoking) and was selected on the basis that it
could not possibly be caused by a young person’s own smoking. Further information regarding
the negative controls can be found in S1 Text.
Statistical analyses
After creating the PRS using PLINK and PRSice software, all analyses were carried out in
STATA 15.1 [18]. Using the logistic command, we conducted a series of logistic regressions
adjusted for age (in months at the time of the outcome measure), sex, and the first 10 principal
components of population stratification (i.e., common subpopulation differences in allele fre-
quencies). We assessed the association between smoking initiation PRS and (i) ever e-cigarette
use by age 24 among the full sample and those who had never smoked, (ii) regular e-cigarette
use at age 24, (iii) smoking initiation, and (iv) negative control outcomes (risk-taking behav-
iours, externalising disorders, and SEP). All analyses were repeated for each of the 5 p-value
thresholds for determining SNP inclusion in the PRS. We also assessed the association between
the main outcome of interest (e-cigarette use) and each negative control outcome. These analy-
ses were planned prior to the analysis being conducted and were not data driven; however, the
plan was not made publicly available prior to the analysis.
Results
A total of 378 SNPs were identified as genome-wide significant in the GSCAN GWAS of
smoking initiation [9], 356 of which were available in ALSPAC. Nine SNPs were removed at
the clumping stage, leaving 347 SNPs included in the most stringent PRS (p-value threshold
p< 5 × 10−8). The number of SNPs included in each PRS at the less stringent thresholds is
shown in S2 Table. Of note, PRS calculated at these less stringent thresholds were based on the
significance level reported in the restricted sample (excluding ALSPAC and 23andMe) sum-
mary data.
Table 1 shows the characteristics of the sample; 878 (30%) young adults were self-reported
ever e-cigarette users by 24 years, and 1,695 (64%) were self-reported ever smokers. Of those
who had ever used an e-cigarette, 95% (n = 830) had ever smoked at least one whole cigarette,
and 71% (n = 616) had smoked 100 or more cigarettes. Less than 1% of the sample had used an
e-cigarette prior to smoking. Self-reported smoking and e-cigarette use were associated with
lower parental SEP and having externalising disorders in childhood (S3 Table). Self-reported
smoking and e-cigarette use were also associated with increased odds of engaging in risk-tak-
ing behaviours (S3 Table).
Smoking initiation PRS and self-reported smoking
We observed positive associations between smoking initiation PRS and ever smoking (having
smoked at least 1 cigarette in a lifetime) by the age of 24 years (p< 5 × 10−8 threshold OR
(OR10-8) = 1.25, 95% CI 1.16 to 1.35, p< 0.001) and smoking initiation (having smoked at
least 100 cigarettes in a lifetime) by the age of 24 years (OR10-8 = 1.29, 95% CI 1.19 to 1.39,
p< 0.001). We found strong associations between smoking initiation PRS and self-reported
smoking measures at all p-value thresholds (Table 2).
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Smoking initiation PRS and self-reported e-cigarette use
We observed positive associations between smoking initiation PRS and self-reported ever use
of e-cigarettes by the age of 24 years (OR10-8 = 1.24, 95% CI 1.14 to 1.34, p< 0.001) and self-
reported regular (at least once a month) e-cigarette use at 24 years (OR10-8 = 1.18, 95% CI 1.00
to 1.40, p = 0.049). We observed these associations at all p-value thresholds (Table 2). Among
those who had never initiated smoking (i.e., smoked<100 cigarettes in their lifetime), we
found no clear evidence for an association between smoking initiation PRS and ever e-ciga-
rette use at the most stringent p-value thresholds. However, we found evidence of a positive
association with PRS calculated using less stringent thresholds (p< 0.5 threshold OR = 1.18,
95% CI 1.04 to 1.35, p = 0.012; Table 2). We found similar patterns of association among those
who had never smoked any cigarettes (S4 Table).
Smoking initiation PRS and negative controls
We observed a positive association between smoking initiation PRS and high number of sexual
partners by 23 years (OR10-8 = 1.15, 95% CI 1.05 to 1.26, p = 0.003) and having ever gambled
by 24 years (OR10-8 = 1.12, 95% CI 1.03 to 1.22, p = 0.008) at all p-value thresholds (Table 3).
We found some evidence of a positive association between smoking initiation PRS and enjoy-
ing taking risks at 24 years (OR0.005 = 1.11, 95% CI 1.03 to 1.19, p = 0.005), but this was less
clear at the more stringent thresholds (Table 3). There was no clear evidence of an association
between smoking initiation PRS and having been in trouble with the law since their 23rd birth-
day (Table 3).
We found evidence of a positive association between smoking initiation PRS and hyperac-
tivity at 7 years (OR0.0005 = 1.10, 95% CI 1.04 to 1.16, p = 0.001) but not at the most stringent
threshold (Table 4). There was also a positive association with CD at 7 years (OR10-8 = 1.10,
95% CI 1.03 to 1.17, p = 0.004) at all thresholds (Table 4). There was some evidence of a
Table 1. Characteristics of young adults in ALSPAC.
Characteristic N (%)
Ever used an e-cigarette by 24 (used once or more) 878 (30%)
Regularly used an e-cigarette at 24 (used at least once a month) 150 (5%)
Ever smoked by 24 (1 cigarette or more) 1,695 (64%)
Initiated smoking by 24 (100 cigarettes or more) 972 (33%)
Ever used an e-cigarette but not initiated smoking by 24 262 (13%)
High number of sexual partners at 23� 647 (25%)
Been in trouble with the law since 23rd birthday 69 (2%)
Enjoys taking risks at 24 1,618 (55%)
Ever gambled at 24 2,156 (74%)
Hyperactivity at 7 2,219 (42%)
Conduct disorder at 7 1,199 (22%)
Oppositional defiant disorder at 7 1,868 (35%)
Parental SEP (manual) 1,068 (27%)
Mean (SD)
Age in months at 24-year questionnaire 298 (6)
Sample sizes varied by characteristic due to differing time points of measurement (i.e., missing data).
�Eleven or more sexual partners, determined using the upper quartile for number of lifetime sexual partners in the
ALSPAC sample (11 sexual partners).
ALSPAC, Avon Longitudinal Study of Parents and Children; SEP, socioeconomic position.
https://doi.org/10.1371/journal.pmed.1003555.t001
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positive association between PRS and ODD specifically at the 0.0005 threshold (OR0.0005 =
1.08, 95% CI 1.02 to 1.14, p = 0.013). We also found a positive association with lower parental
SEP (OR10-8 = 1.08, 95% CI 1.01 to 1.16 p = 0.017) at all thresholds (Table 5).
Discussion
In this study, we explored the association between smoking initiation PRS and e-cigarette use,
using logistic regression. We further explored the findings by observing the association
between smoking initiation PRS and positive controls (smoking) and negative controls (e.g.,
risk-taking), as well as restricting the analysis to never smokers. Smoking initiation PRS were
strongly associated with ever e-cigarette use by 24 years whereby higher genetic liability to
smoking initiation was associated with a 24% increase in the likelihood of ever using an e-




n OR 95% CI p
Ever e-cigarette use by age 24 2,894
5 × 10−8 1.24 1.14, 1.34 <0.001
0.0005 1.27 1.17, 1.38 <0.001
0.005 1.36 1.26, 1.48 <0.001
0.05 1.39 1.28, 1.51 <0.001
0.5 1.39 1.28, 1.51 <0.001
Regular e-cigarette use at age 24 (at least once a month) 2,894
5 × 10−8 1.18 1.00, 1.40 0.049
0.0005 1.22 1.03, 1.44 0.019
0.005 1.22 1.04, 1.44 0.017
0.05 1.18 1.00, 1.39 0.051
0.5 1.22 1.04, 1.44 0.018
Ever smoking by age 24 (1 cigarette or more) 2,931
5 × 10−8 1.25 1.16, 1.35 <0.001
0.0005 1.27 1.17, 1.38 <0.001
0.005 1.32 1.22, 1.43 <0.001
0.05 1.33 1.23, 1.44 <0.001
0.5 1.34 1.24, 1.44 <0.001
Smoking initiation (100 cigarettes or more) by age 24 2,925
5 × 10−8 1.29 1.19, 1.39 <0.001
0.0005 1.38 1.27, 1.49 <0.001
0.005 1.46 1.34, 1.58 <0.001
0.05 1.49 1.37, 1.61 <0.001
0.5 1.49 1.37, 1.39 <0.001
Ever e-cigarette use by age 24 among never smokers (<100 cigarettes) 1,937
5 × 10−8 1.10 0.97, 1.26 0.150
0.0005 1.05 0.92, 1.20 0.464
0.005 1.12 0.98, 1.28 0.087
0.05 1.15 1.00, 1.31 0.046
0.5 1.18 1.04, 1.35 0.012
Ever smoking and smoking initiation models were included as positive controls. Analyses were adjusted for age, sex,
and principal components 1–10.
OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003555.t002
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cigarette (per standard deviation (SD) increase in PRS). As expected, we observed an associa-
tion of smoking initiation PRS and both ever smoking and smoking initiation. It was notable
that the associations of the smoking initiation PRS and both smoking and e-cigarette use were
of similar magnitude. Given the small amount of variation in smoking initiation explained by
the SNPs (2.3%), and the fact that any causal effect will only explain a proportion of the out-
come, these small effect sizes are to be expected. Interestingly, we also observed positive associ-
ations between smoking initiation PRS and risk-taking, impulsivity, and parental SEP at birth.
In contrast to the results of Allegrini and colleagues [6], we found an association between ever
e-cigarette use and smoking initiation predisposition where they only found an association with
smoking heaviness predisposition. This is likely due to the use of different SNPs to create the
score; our score was based on the findings of a recent, large GWAS (GSCAN [9]; N = 1,232,091),
whereas Allegrini and colleagues [6] based their score on an earlier GWAS with a much smaller
sample (the Tobacco and Genetics Consortium [14]; N = 69,207). Thus, there was greater statisti-
cal power to detect genome-wide significant associations in the GWAS we based our score on.




n OR 95% CI p
11 or more sexual partners by age 23� 2,505
5 × 10−8 1.15 1.05, 1.26 0.003
0.0005 1.12 1.02, 1.23 0.019
0.005 1.18 1.08, 1.29 <0.001
0.05 1.25 1.14, 1.37 <0.001
0.5 1.30 1.19, 1.43 <0.001
Been in trouble with the law since 23rd birthday 2,928
5 × 10−8 1.00 0.79, 1.28 0.988
0.0005 1.12 0.88, 1.43 0.352
0.005 1.11 0.87, 1.41 0.407
0.05 1.04 0.82, 1.33 0.745
0.5 0.90 0.71, 1.15 0.394
Enjoys taking risks at age 24 2,932
5 × 10−8 1.06 0.98, 1.14 0.154
0.0005 1.05 0.98, 1.14 0.163
0.005 1.11 1.03, 1.19 0.005
0.05 1.09 1.01, 1.17 0.029
0.5 1.08 1.01, 1.16 0.033
Ever gambled by age 24 2,899
5 × 10−8 1.12 1.03, 1.22 0.008
0.0005 1.16 1.07, 1.26 0.001
0.005 1.16 1.06, 1.26 0.001
0.05 1.20 1.10, 1.30 <0.001
0.5 1.15 1.06, 1.25 0.001
Number of sexual partners, trouble with the law, enjoying risk-taking, and gambling models were included as
negative controls. Analyses were adjusted for age, sex, and principal components 1–10.
�Low (<11) vs. high (11 or more) number of sexual partners, determined using the upper quartile for number of
lifetime sexual partners in the ALSPAC sample (11 sexual partners).
ALSPAC, Avon Longitudinal Study of Parents and Children; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003555.t003
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The association between smoking initiation PRS and e-cigarette use could be explained by
smoking causally influencing e-cigarette use. This hypothesis is supported by observational
evidence; use of e-cigarettes for smoking cessation is common among both young adults in the
UK [4] and adults in Great Britain [19]. However, the associations observed among the
restricted analysis and between the negative control outcomes suggest there may be other fac-
tors at play—there may be shared genetic risk factors that influence both behaviours. Among




n OR 95% CI p
Hyperactivity at age 7 5,227
5 × 10−8 1.02 0.96, 1.08 0.511
0.0005 1.10 1.04, 1.16 0.001
0.005 1.14 1.08, 1.20 <0.001
0.05 1.14 1.08, 1.21 <0.001
0.5 1.15 1.08, 1.21 <0.001
Conduct disorder at age 7 5,334
5 × 10−8 1.10 1.03, 1.17 0.004
0.0005 1.11 1.04, 1.19 0.001
0.005 1.11 1.04, 1.18 0.002
0.05 1.08 1.01, 1.15 0.021
0.5 1.08 1.01, 1.15 0.017
Oppositional defiant disorder at age 7 5,325
5 × 10−8 1.02 0.96, 1.08 0.496
0.0005 1.08 1.02, 1.14 0.013
0.005 1.04 0.98, 1.10 0.200
0.05 1.04 0.98, 1.10 0.173
0.5 1.02 0.96, 1.08 0.529
Hyperactivity and conduct disorder were assessed using the strengths and difficulties questionnaire (SDQ), and
oppositional defiant disorder was assessed using the development and wellbeing assessment (DAWBA). All variables
were recoded into binary outcomes (no disorder/symptoms versus borderline/disorder/symptoms).
DAWBA, development and wellbeing assessment; OR, odds ratio; SDQ, strengths and difficulties questionnaire.
https://doi.org/10.1371/journal.pmed.1003555.t004




n OR 95% CI p
Parental SEP (manual) 6,702
5 × 10−8 1.08 1.01, 1.16 0.017
0.0005 1.13 1.06, 1.21 <0.001
0.005 1.16 1.09, 1.24 <0.001
0.05 1.11 1.03, 1.18 0.003
0.5 1.13 1.05, 1.20 <0.001
Parental SEP was based on the higher of the mother or partner’s occupational social class using the Office of
Population Censuses and Surveys (OPCS) occupation codes.
OPCS, Office of Population Censuses and Surveys; OR, odds ratio; SEP, socioeconomic position.
https://doi.org/10.1371/journal.pmed.1003555.t005
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never smokers, we found weak evidence of an association between smoking initiation PRS and
e-cigarette use, which suggests that the e-cigarette use is not simply caused by smoking (which
has not occurred in these cases) but that there is a shared genetic aetiology influencing both
behaviours. Hence, what appears to be a gateway between e-cigarette use and smoking in pre-
vious studies [5] could actually be a shared genetic liability, and the order of use is coincidental
or due to other factors such as perceived risk or misreporting of smoking status [20].
Alternatively, the smoking initiation PRS may be capturing much more than just smoking
or nicotine use. Using less stringent p-value thresholds to create PRS increases the percentage
variance in the phenotype explained by the score, and therefore the power to detect an associa-
tion up to a point; using less stringent thresholds also increases the likelihood of capturing
SNPs which are related to other factors, which adds noise and eventually results in less specific
PRS that explain less variance in the exposure and more variance in other (horizontally pleio-
tropic) effects. Increasing magnitudes and strengthened evidence of association with PRS and
negative controls at less stringent p-value thresholds suggests that the smoking initiation PRS
is capturing, at least in part, a broad phenotype which is not entirely specific to smoking/nico-
tine. Although weaker associations were observed between risk-taking factors and PRS for
smoking initiation compared to e-cigarette use and smoking, the associations are still relatively
strong and consistent. Recent observational evidence also indicated a strong association
between e-cigarette use and smoking prior to adjusting for risk-taking behaviours and other
shared risk factors but showed no clear evidence of an association after adjusting for risk-tak-
ing behaviours and other shared risk factors [21]. We also found an association between the
smoking initiation PRS and externalising disorders in childhood (7 years) which precedes the
age at which cigarettes are first smoked in the vast majority of cases in this cohort (>99%) and
therefore cannot be a causal effect of own smoking. However, this association could potentially
be due to causal in utero effects of maternal smoking in pregnancy or maternal smoking in
childhood, since maternal and offspring genotype will be correlated. Nevertheless, combined
with evidence that liability to attention-deficit/hyperactivity disorder (ADHD) increases the
likelihood of smoking initiation and vice versa [22], our results suggest the possibility that the
smoking initiation PRS is capturing a broad impulsivity phenotype. The association observed
between PRS for smoking initiation and parental SEP also suggests the PRS could be capturing
sociodemographic factors as well as smoking. Alternatively, there may be a dynastic effect
whereby parental predisposition to smoking (which is correlated with their child’s genetic pre-
disposition) influences parental SEP at birth. The apparent association of the child’s genotype
could actually be an outcome of parental genetic predisposition,
Despite the strengths of this study (which include the use of a well-powered GWAS to cre-
ate our score, lack of overlap between samples, and use of negative controls to explore potential
mechanistic pathways), there are a number of limitations of this study. First, the relatively low
sample size—particularly when investigating associations with regular e-cigarette use and
restricting to never smokers. Second, restricting analysis to never smokers could introduce col-
lider bias [23]. We found that smoking initiation PRS were strongly associated with smoking
initiation; if e-cigarette use causes young adults to smoke, then smoking status is a collider and
conditioning on this variable (i.e., restricting analysis to never smokers) may inflate any associ-
ation between smoking initiation PRS and e-cigarette use. Third, this cohort is not appropriate
to directly study the gateway hypothesis as the young adults in ALSPAC were approximately
17 years old when e-cigarettes became widely available and therefore were exposed to ciga-
rettes earlier in their adolescence than e-cigarettes and had more opportunity to smoke than
use e-cigarettes than later birth cohorts. Future research should explore this association in a
larger sample of individuals with exposure to both cigarettes and e-cigarettes during adoles-
cence. Fourth, the attrition rate in ALSPAC is considerable—only 2,905 of the 7,859
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nonrelated participants of European ancestry with genetic data responded to the questions
about e-cigarette use in the 24 year questionnaire—and missingness in this cohort has previ-
ously been associated with smoking initiation PRS [24]. Replicating the participation scores
used by Taylor and colleagues [24], we found that higher smoking initiation PRS were associ-
ated with participating in fewer ALSPAC questionnaires and clinics (change in participation
per SD increase in smoking initiation PRS [p< 5 × 10−8 threshold] = −1.15, 95% CI −1.53 to
−0.76, p< 0.001). Furthermore, we found that those with higher smoking initiation PRS were
less likely to have been included in the analysis of smoking initiation PRS and e-cigarette use
due to attrition (OR10-8 per SD of smoking initiation PRS = 0.87, 95% CI 0.83 to 0.91,
p< 0.001) so our estimates may be biased by selection and the association could be stronger
than observed here. However, interpretation of any study including smoking initiation PRS
will be difficult as the association between smoking initiation PRS and attrition could induce
bias such as collider bias [25]. Fifth, the variability in the nature of the key assessments and the
use of self-reports may have resulted in measurement error of the phenotype and outcomes.
The associations observed here may have implications for the use of smoking initiation PRS
in mendelian randomisation (MR) analysis. This method is often implemented to provide
unconfounded causal estimates, as long as the assumptions of MR hold [26]. One assumption
is that the genetic instrument (e.g., smoking initiation PRS) is not associated with any con-
founders (e.g., risk-taking, childhood externalising disorders, SEP). The association we
observed between smoking initiation PRS and negative control outcomes, even when
restricted to only genome-wide significant SNPs, indicates that smoking initiation PRS may
not be a valid instrument to use in MR to investigate the causal effects of smoking initiation.
This emphasises the importance of using pleiotropy robust methods (e.g., MR Egger). The
InSIDE (Instrument Strength Independent of Direct Effect) assumption requires that SNP-
exposure effects (e.g., the effect of smoking initiation SNPs on smoking initiation) should not
be correlated with horizontal pleiotropic effects (e.g., the effect of smoking initiation SNPs on
broad risk-taking behaviour). The association observed between the smoking initiation PRS
and multiple risk-taking behaviours and externalising disorders in childhood suggests that the
smoking initiation SNPs may be capturing a broader phenotype, such as risk-taking, which is
not specific to smoking or nicotine, and thus this assumption may be violated. One approach
which could be used to address this is Steiger filtering which can be used to exclude SNPs
which explain the variance in the outcome over and above the variance in the exposure
[11,27]. The same approach can be applied in MR studies using smoking initiation PRS to
remove SNPs which explain more variance in the negative control outcomes used in this study
(or other phenotypes/proxies for risk-taking behaviour) than variance in smoking initiation.
However, if the InSIDE assumption is perfectly violated (i.e., if the SNP effect on broad risk-
taking causes smoking initiation), the smoking initiation PRS will be an invalid instrument
using any MR method. At the very least, triangulating evidence across multiple MR methods
(e.g., median weighted and mode based) would be advised in MR studies using smoking initia-
tion PRS but, ideally, other causal inference methods should also be used. Further research
could also explore the potential mediating effects of the positive and negative controls included
in this analysis; if a PRS for e-cigarette initiation is identified in a GWAS, pleiotropy robust
multivariable MR methods [28] could be employed to explore mediating effects using smoking
initiation, e-cigarette initiation, and risk-taking PRS (providing the PRS are sufficiently inde-
pendent from one another).
The results also provide support for a shared genetic liability between e-cigarette use and
smoking, which may have implications for policy; strict policies (e.g., bans), which aim to pre-
vent e-cigarette use in order to reduce the risk of smoking initiation among youth and young
adults, may not be effective. In fact, they may have the opposite effect; if young people are
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predisposed to both e-cigarette use and smoking but only cigarettes are available, this could
increase their likelihood of smoking because it is the only option available to them. Further-
more, such policies may prevent and discourage adult smokers from accessing an effective
smoking cessation tool and hamper smoking cessation attempts and could therefore have a
negative impact on smoking rates. Ideally, policy should prevent use by nonsmokers but pro-
mote use by smokers for smoking cessation.
In conclusion, we find evidence to suggest there is a shared genetic aetiology between smok-
ing and e-cigarette use but also with risky behaviour, SEP, and externalising disorders in child-
hood. This suggests the PRS for smoking initiation is not specific to smoking or nicotine use
but is capturing something much broader. Future research is needed to explore this in a popu-
lation which has been exposed to both e-cigarettes and cigarettes in adolescence.
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